Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs77375493
rs77375493
T 0.750 CausalMutation CLINVAR

dbSNP: rs1232880706
rs1232880706
A 0.700 CausalMutation CLINVAR

dbSNP: rs1565295267
rs1565295267
A 0.700 GeneticVariation CLINVAR

dbSNP: rs754190776
rs754190776
0.010 GeneticVariation BEFREE A new abnormal hemoglobin, Hb Villejuif [beta 123(H1) Thr----Ile] has been discovered during the exploration of a polycythemia in a 87-year-old patient of French origin. 2816924

1989

dbSNP: rs33927093
rs33927093
HBB
0.010 GeneticVariation BEFREE Hb Puttelange [beta 140(H18)Ala-->Val] was found as a de novo mutation in two siblings of a French family suffering from polycythemia. 8522332

1995

dbSNP: rs35594230
rs35594230
HBB
0.010 GeneticVariation BEFREE Hb Puttelange [beta 140(H18)Ala-->Val] was found as a de novo mutation in two siblings of a French family suffering from polycythemia. 8522332

1995

dbSNP: rs142094773
rs142094773
0.010 GeneticVariation BEFREE However, the Epo-R mutation (N487S) that we describe is located in the same tyrosine sequence beginning at AA 485 as the one previously observed (P488S) in as case of polycythemia (Sokol et al, Exp Hematol 22:447, 1994). 8608241

1996

dbSNP: rs62638745
rs62638745
0.010 GeneticVariation BEFREE However, the Epo-R mutation (N487S) that we describe is located in the same tyrosine sequence beginning at AA 485 as the one previously observed (P488S) in as case of polycythemia (Sokol et al, Exp Hematol 22:447, 1994). 8608241

1996

dbSNP: rs28940298
rs28940298
VHL
0.030 GeneticVariation BEFREE We report on five Caucasian patients with congenital polycythemia and mutations of the von Hipple-Lindau (VHL) gene: a compound heterozygote for the novel exon 1 (VHL 235C->T) and previously reported VHL 562C->G mutations; three homozygotes for Chuvash VHL 598C->T mutation; and a heterozygote for VHL 523->G mutation who also has ataxia-telangiectasia; a rare autosomal disease of childhood onset. 15642680

2005

dbSNP: rs200885420
rs200885420
VHL
0.010 GeneticVariation BEFREE We report on five Caucasian patients with congenital polycythemia and mutations of the von Hipple-Lindau (VHL) gene: a compound heterozygote for the novel exon 1 (VHL 235C->T) and previously reported VHL 562C->G mutations; three homozygotes for Chuvash VHL 598C->T mutation; and a heterozygote for VHL 523->G mutation who also has ataxia-telangiectasia; a rare autosomal disease of childhood onset. 15642680

2005

dbSNP: rs5030824
rs5030824
VHL
0.010 GeneticVariation BEFREE We report on five Caucasian patients with congenital polycythemia and mutations of the von Hipple-Lindau (VHL) gene: a compound heterozygote for the novel exon 1 (VHL 235C->T) and previously reported VHL 562C->G mutations; three homozygotes for Chuvash VHL 598C->T mutation; and a heterozygote for VHL 523->G mutation who also has ataxia-telangiectasia; a rare autosomal disease of childhood onset. 15642680

2005

dbSNP: rs201051019
rs201051019
EPO
0.010 GeneticVariation BEFREE In one out of six young individuals with polycythemia and high erythropoietin levels we found a heterozygous VHL gene mutation (430G->A;Gly144Arg). 15921386

2005

dbSNP: rs869025650
rs869025650
VHL
0.010 GeneticVariation BEFREE In one out of six young individuals with polycythemia and high erythropoietin levels we found a heterozygous VHL gene mutation (430G->A;Gly144Arg). 15921386

2005

dbSNP: rs869025650
rs869025650
VHL
0.010 GeneticVariation BEFREE In one out of six young individuals with polycythemia and high erythropoietin levels we found a heterozygous VHL gene mutation (430G->A;Gly144Arg). 15921386

2005

dbSNP: rs77375493
rs77375493
0.750 GeneticVariation BEFREE This work demonstrates that JAK2(V617F) is sufficient for polycythemia and fibrosis development and offers an in vivo model to assess novel therapeutic approaches for JAK2(V617F)-positive pathologies. 16670266

2006

dbSNP: rs77375493
rs77375493
0.750 GeneticVariation BEFREE Molecular pathogenesis and therapy of polycythemia induced in mice by JAK2 V617F. 17183644

2006

dbSNP: rs77375493
rs77375493
0.750 GeneticVariation BEFREE The somatic JAK2 valine-to-phenylalanine (V617F) mutation has been detected in up to 90% of patients with polycythemia and in a sizeable proportion of patients with other myeloproliferative disorders such as essential thrombocythemia and idiopathic myelofibrosis. 17317861

2007

dbSNP: rs77375493
rs77375493
0.750 GeneticVariation BEFREE These results demonstrate that STAT5a/b is essential for the induction of CML-like leukemia by BCR-ABL1 and of polycythemia by JAK2(V617F), and validate STAT5a/b and the genes they regulate as targets for therapy in these MPNs. 22234689

2012

dbSNP: rs77375493
rs77375493
0.750 GeneticVariation BEFREE The JAK2(V617F) mutation occurred in 27% of SP patients diagnosed according to the Polycythemia Vera Study Group or World Health Organization 2001 criteria. 22262773

2012

dbSNP: rs28940298
rs28940298
VHL
0.030 GeneticVariation BEFREE This observation contrasts with a report suggesting that polycythemia in VHL R200W and H191D homozygotes is due to the loss of JAK2 regulation from VHL R200W and H191D binding to SOCS1. 23403324

2013

dbSNP: rs28940301
rs28940301
VHL
0.020 GeneticVariation BEFREE The phenotype of polycythemia due to Croatian homozygous VHL (571C>G:H191D) mutation is different from that of Chuvash polycythemia (VHL 598C>T:R200W). 23403324

2013

dbSNP: rs28940301
rs28940301
VHL
0.020 GeneticVariation BEFREE This observation contrasts with a report suggesting that polycythemia in VHL R200W and H191D homozygotes is due to the loss of JAK2 regulation from VHL R200W and H191D binding to SOCS1. 23403324

2013

dbSNP: rs771912975
rs771912975
0.010 GeneticVariation BEFREE The phenotype of polycythemia due to Croatian homozygous VHL (571C>G:H191D) mutation is different from that of Chuvash polycythemia (VHL 598C>T:R200W). 23403324

2013

dbSNP: rs775387828
rs775387828
0.010 GeneticVariation BEFREE However, now we describe a new homozygous VHL exon 2 mutation of the VHL gene:(c.413C>T):P138L, which is associated in the affected homozygote with congenital polycythemia but not in her, or her-heterozygous relatives, with cancer or other VHL syndrome tumors. 23538339

2013

dbSNP: rs780178275
rs780178275
VHL
0.010 GeneticVariation BEFREE However, now we describe a new homozygous VHL exon 2 mutation of the VHL gene:(c.413C>T):P138L, which is associated in the affected homozygote with congenital polycythemia but not in her, or her-heterozygous relatives, with cancer or other VHL syndrome tumors. 23538339

2013